RECURRENT PERITONEAL MALIGNANT MESOTHELIOMA
Clinical trials for RECURRENT PERITONEAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PERITONEAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for RECURRENT PERITONEAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat cancers: experimental drug aims to boost chemo power
Disease control OngoingThis study is testing a new oral drug called TRC102 (methoxyamine) to see if it can make standard chemotherapy drugs more effective against advanced solid tumors and mesothelioma. It aims to find the safest dose and see if the combination can shrink tumors in patients whose cance…
Matched conditions: RECURRENT PERITONEAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, atezolizumab and bevacizumab, can help control several rare types of advanced solid tumors. The trial is for adults whose cancer has spread or returned after other treatments. The goal is to see if this drug …
Matched conditions: RECURRENT PERITONEAL MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC